Arcturus Therapeutics: Q1 Earnings Snapshot

Published: 2026-05-07 16:50:21 ET ARCT

Published on 05/07/2026 at 04:50 pm EDT

SAN DIEGO (AP) — SAN DIEGO (AP) — Arcturus Therapeutics (ARCT) on Thursday reported a loss of $27 million in its first quarter.

The San Diego-based company said it had a loss of 95 cents per share.

The results topped Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of $1.14 per share.

The pharmaceutical company posted revenue of $2.1 million in the period, missing Street forecasts. Five analysts surveyed by Zacks expected $7.9 million.

Arcturus Therapeutics shares have risen 45% since the beginning of the year. In the final minutes of trading on Thursday, shares hit $8.90, a drop of 19% in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ARCT at https://www.zacks.com/ap/ARCT

For copyright information, check with the distributor of this item, STATS Perform dba Automated Insights. , source Associated Press News